Search
Search Results
-
BACTERIAL MENINGITIDIS AND ITS COMPLICATIONS
This article analyzes the epidemiology, clinical manifestations, laboratory diagnostic methods, treatment approaches, and preventive measures related to Neisseria meningitidis infection. Currently, this bacterium remains a major cause of high mortality and disability, particularly among children, adolescents, and immunocompromised individuals. Meningococcal infection typically begins suddenly and presents with age-dependent clinical symptoms. The article highlights the distribution dynamics of invasive meningococcal disease (IMD) by serogroups (A, B, C, W, X, and Y) and their regional differences. In diagnostics, molecular methods—especially PCR technology targeting the sodC and ctrA genes—have shown high sensitivity. Broad-spectrum antibiotics such as penicillin and ceftriaxone, along with anti-inflammatory therapy using dexamethasone, play crucial roles in treatment. Modern approaches, such as cerebrospinal fluid (CSF) drainage, have also proven beneficial in reducing mortality and complications. Vaccines serve as effective preventive tools against infection, with both multivalent conjugate and protein-based formulations being widely used. Additionally, N. meningitidis can, in some cases, cause conjunctivitis and neonatal infections. The article emphasizes the broad clinical spectrum of these infections, contemporary diagnostic and therapeutic strategies, and their importance within the healthcare system.